We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
- Authors
Omar, H; Hägglund, H; Gustafsson-Jernberg, A; LeBlanc, K; Mattsson, J; Remberger, M; Ringdén, O; Sparrelid, E; Sundin, M; Winiarski, J; Yun, Z; Ljungman, P
- Abstract
Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disease (PTLD) is a serious complication after allogeneic stem cell transplantation (SCT). The likelihood of PTLD is increased in the presence of specific risk factors. Monitoring of EBV DNA load and early administration of rituximab in patients with high EBV loads is recommended for high-risk patients.
- Publication
Transplant infectious disease : an official journal of the Transplantation Society, 2009, Vol 11, Issue 5, p393
- ISSN
1399-3062
- Publication type
Journal Article
- DOI
10.1111/j.1399-3062.2009.00410.x